RE:I like you “ red flags, I’ll address one at a time”Don't rely on one RBC analyst when he doesn't include pelareorep + immune checkpoint inhibitors in multiple cancers. Furthermore US$ 5 Billion in sales = US$ 82 earnings per share. On earnings of $82 per share and a 20 price to earnings (p/e) the valuation would be (82 x 20) $1640 per share x # outstanding shares = $100 Billion